Neurowyzr provides detection, diagnosis, therapy, monitoring, and prevention of brain decline.
Neurowyzr has raised $2.1M in total funding. The most recent round was Seed. The last funding was announced in August 2023.
Neurowyzr's investors include Peak XV Partners, Jungle Ventures, Khoo Boon Hui, Abhishek Gaur, Rob F Jablonski.
Neurowyzr is headquartered in Bukit Merah, Singapore.
Neurowyzr provides detection, diagnosis, therapy, monitoring, and prevention of brain decline.
Neurowyzr is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neurowyzr — Funding & Investors." VCBacked, August 14, 2023, https://www.vcbacked.co/company/neurowyzr. Accessed July 20, 2026.
VCBacked. (2023). Neurowyzr — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/neurowyzr
{{cite web |title=Neurowyzr — Funding & Investors |url=https://www.vcbacked.co/company/neurowyzr |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated